mLabs® S100β

Clinical Significances

• Early diagnosis, judgment of injury degree and prognosis of traumatic craniocerebral injury.

• Early auxiliary diagnosis of acute stroke, evaluation of cerebral injury degree, guidance of treatment and

evaluation of prognosis.

• Diagnosis of brain injury caused by central nervous system infection.

• Early diagnosis and prognosis of neonatal hypoxic-ischemic encephalopathy (HIE).

Features
• Fast - quantitative results in 10~15 minutes

• Simple - Whole blood sample testing, no centrifuge or laboratory equipment is required

• Accurate - patented microfluidic technology enables highly precise fluorescence immunoassay testing

Package Specifications
25 tests / box